Universe Pharmaceuticals (UPC) Non-Current Assets (2020 - 2026)
Universe Pharmaceuticals (UPC) posted Non-Current Assets of $16.3 million for Q1 2026, up 3.54% sequentially from $15.7 million in Q3 2025.
Universe Pharmaceuticals (UPC) Non-Current Assets (2020 - 2026) Analysis & Trends
Universe Pharmaceuticals has reported Non-Current Assets for 7 years, with the latest figure at $16.3 million in Q1 2026.
- Quarterly Non-Current Assets changed N/A year-over-year to $16.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.3 million (changed N/A YoY) and the FY2025 annual result came in at $15.7 million, down 99.9% from the prior year.
- Non-Current Assets advanced to $16.3 million in Q1 2026 per UPC's latest filing, from $15.7 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $16.3 billion in Q3 2024 and troughed at $15.7 million in Q3 2025.
- A 5-year average of $2.1 billion and a median of $17.2 million in 2023 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets jumped 99054.25% in 2024, then slumped 99.9% in 2025.
- Over 5 years, Non-Current Assets stood at $18.0 million in 2022, then slipped by 8.76% to $16.5 million in 2023, then surged by 99054.25% to $16.3 billion in 2024, then plunged by 99.9% to $15.7 million in 2025, then rose by 3.54% to $16.3 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $16.3 million, $15.7 million, and $16.3 billion for Q1 2026, Q3 2025, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.96 Bn |
| 10 | Universe Pharmaceuticals | 3.04 Mn | -26.01 Mn | - | 16.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.26 Mn |
| Sep 30, 2025 | 15.70 Mn |
| Sep 30, 2024 | 16.32 Bn |
| Mar 31, 2024 | 15.90 Mn |
| Sep 30, 2023 | 16.45 Mn |
| Mar 31, 2023 | 17.85 Mn |
| Sep 30, 2022 | 18.03 Mn |
| Mar 31, 2022 | 19.71 Mn |
| Sep 30, 2021 | 19.66 Mn |
| Sep 30, 2020 | 5,524.38 Bn |